Interleukin-1

Cytokine and Growth Factor Reviews

Volumn 8, Issue 4, 1997, Pages 253-265

  Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Host defense; IL 1 converting enzyme; Inflammation; Tumor necrosis factor

Indexed keywords

CYSTEINE PROTEINASE; GUANOSINE TRIPHOSPHATASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN KINASE (CALCIUM,CALMODULIN); SIALOGLYCOPROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; ENZYME ACTIVATION; GENETICS; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; METABOLISM; NONHUMAN; PHYSIOLOGY; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031410649     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(97)00023-3     Document Type: Short Survey

References (142)

1. 1. Bazan JF, Timans JC, Kaselein RA. A newly defined interleukin-1? Nature 1996, 379, 591.
2. 2. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261, 472-475.
3. 3. Greenfeder SA, Nunes P, Kwee L, et al. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem 1995, 270, 13757-13765.
4. 4. Stevenson FT, Torrano F, Locksley RM, et al. Interleukin-1: the patterns of translation and intracellular distribution support aternative secretory mechanisms. J Cell Physiol 1992, 152, 223-231.
5. 5. Kobayashi Y, Appella E, Yamada M, et al. Phosphorylation of intracellular precursors of human IL-1. J Immunol 1988, 140, 2279-2287.
6. 6. Kobayashi Y, Yamamoto K, Saido T, et al. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci USA 1990, 87, 5548-5552.
7. 7. Miller AC, Schattenberg DG, Malkinson AM, et al. Decreased content of the IL-1α processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. Tox Lett 1994, 74, 177-184.
8. 8. Watanabe N, Kobayashi Y. Selective release of a processed form of interleukin-1α. Cytokine 1994, 6, 597-601.
9. 9. Andersson J, BjÖrk L, Dinarello CA, et al. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992, 22, 2617-2623.
10. 10. Mizel SB, Kilian PL, Lewis JC. et al. The interleukin 1 receptor Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J Immunol 1987, 138, 2906-2912.
11. 11. Heguy A. Baldari C, Bush K. et al. Internalization and nuclear localization of interleukin 1 are not sufficient for function. Cell Growth Differ 1991, 2, 311-315.
12. 12. Weizmann MN, Savage N. Nuclear internalization and DNA binding activities of interleukin-1, interleukin-1 receptor complexes. Biochem Biophys Res Commun 1992, 187, 1166-1171.
13. 13. Maier JAM, Statuto M, Ragnotti G. Endogenous interleukin-1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994, 14, 1845-1851.
14. 14. Wessendorf JHM, Garfinkel S. Zhan X, et al. Identification of a nuclear localization sequence within the structure of the human interleukin-1α precursor. J Biol Chem 1993, 268, 22100-22104.
15. 15. Beuscher HU, Nickells MW, Colten HR. The precursor of interleukin-1α is phosphorylated at residue serine 90. J Biol Chem 1988, 263, 4023-4028.
16. 16. Stevenson FT, Bursten SL, Fanton C, et al. The 31-kDa precursor of interleukin-1α is myristoylated on specific lysines within the 16-kDa N-terminal propiece. Proc Natl Acad Sci USA 1993, 90, 7245-7249.
17. 17. Maier JAM, Voulalas P, Roeder D, et al. Extension of the life span of human endothelial cells by an interleukin-1α antisense oligomer. Science 1990, 249, 1570-1574.
18. 18. Falk W, Hofmeister R. Intracellular IL-1 replaces signaling by the membrane IL-1 type I receptor. Cytokine 1994, 6, 558.
19. 19. Kurt-Jones EA, Beller DI, Mizel SB, et al. Identification of a membrane-associated interleukin-1 in macrophages. Proc Natl Acad Sci USA 1985, 82, 1204-1208.
20. 20. Stevenson FT, Bursten SL, Locksley RM, et al. Myristyl acylation of the tumor necrosis factor-α precursor on specific lysines. J Exp Med 1992, 176, 1053-1062.
21. 21. Brody DT, Durum SK. Membrane IL-1: IL-1α precursor binds to the plasma membrane via a lectin-like interaction. J Immunol 1989, 143, 1183.
22. 22. Kaplanski G, Farnarier C, Kaplanski S, et al. Interleukin-1 induces interleukin-8 from endothelial cells by a juxtacrine mechanism. Blood 1994, 84, 4242-4248.
23. 23. Minnich-Carruth LL, Suttles J, Mizel SB. Evidence against the existence of a membrane form of murine IL-1α. J Immunol 1989, 142, 526.
24. 24. Bailly S, Ferrua B, Fay M, et al. Paraformaldehyde fixation of LPS-stimulated human monocytes: technical parameters permitting the study of membrane IL-1 activity. Eur Cytokine Net 1990, 1, 47-51.
25. 25. Fenton MJ, Vermeulen MW, Clark BD, et al. Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J Immunol 1988, 140, 2267-2273.
26. 26. Jarrous N, Kaempfer R. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J Biol Chem 1994, 269, 23141-23149.
27. 27. Schindler R, Ghezzi P, Dinarello CA. IL-1 induces IL-1. IV. IFN-γ suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J Immunol 1990, 144, 2216-2222.
28. 28. Serkkola E, Hurme M. Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-1β gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur J Biochem 1993, 213, 243-249.
29. 29. Vannier E, Dinarello CA. Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells: comparison with IL-1 receptor antagonist. J Clin Invest 1993, 92, 281-287.
30. 30. Schindler R, Clark BD, Dinarello CA. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 1990, 265, 10232-10237.
31. 31. Schindler R, Gelfand JA, Dinarello CA. Recombinant C5a stimulates transcription rather than translation of IL-1 and TNF; cytokine synthesis induced by LPS IL-1 or PMA. Blood 1990, 76, 1631-1638.
32. 32. Shapiro L, Dinareilo CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 1995, 92, 12230-12234.
33. 33. Kaspar RL, Gehrke L. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1β mRNA show unequal IL-1β protein accumulation but similar polyribosome profiles. J Immunol 1994, 153, 277-286.
34. 34. Miller LC, Isa S, Vannier E, et al. Live Borrelia burgdorferi preferentially activate IL-1β gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest 1992, 90, 906-912.
35. 35. Stoeckle MY, Guan L. High-resolution analysis of gro-α mRNA poly (A) shortening: regulation by interleukin-1β. Nucl Acid Res 1993, 21, 1613-1617.
36. 36. Shapiro L, Panayotatos N, Meydani SN. Ciliary neurotrophic factor combined with soluble receptor inhibits synthesis of pro-inflammatory cytokines and pro-staglandin-E2 in vitro. Exp Cell Res 1994, 215, 51-56.
37. 37. Jobling SA, Auron PE, Gurka G, et al. Biological activity and receptor binding of human prointerleukin-1β and subpeptides. J Biol Chem 1988, 263, 16372.
38. 38. Bakouche O, Brown DC, Lachman LB. Subcellular localization of human monocyte interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL 1 release. J Immunol 1987, 138, 4249-4255.
39. 39. Rubartelli A, Cozzolino F, Talio M, et al. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 1990, 9, 1503-1510.
40. 40. Auron PE, Warner SJ, Webb AC, et al. Studies on the molecular nature of human interleukin 1. J Immunol 1987. 138, 1447-1456.
41. 41. Beuscher HU, Guenther C, Roellinghoff M. IL-1β is secreted by activated murine macrophages as biologically inactive precursor. J Immunol 1990, 144, 2179-2183.
42. 42. Black RA, Kronheim SR, Cantrell M, et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 1988, 263, 9437-9442.
43. 43. Fantuzzi G, Ku G, Harding MW, et al. Response to local inflammation of IL-1β converting enzyme-deficient mice. J Immunol 1997, 158, 1818-1824.
44. 44. Wilson KP, Black JA, Thomson JA, et al. Structure and mechanism of interleukin-1β converting enzyme. Nature 1994, 370, 270-275.
45. 45. Gu Y, Wu J, Faucheu C. Interleukin-1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 1995, 14, 1923-1931.
46. 46. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996, 87, 123.
47. 47. Walker NP, Talanian RV, Brady KD, et al. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 1994, 78, 343-352.
48. 48. Dinarello CA, Cannon JG, Mier JW, et al. Multiple biological activities of human recombinant, interleukin 1. J Clin Invest 1986, 77, 1734-1739.
49. 49. Irmler M, Hertig S, MacDonald HR, et al. Granzyme A is an interleukin-1β-converting enzyme. J Exp Med 1995, 181, 1917-1922.
50. 50. Higgins GC, Foster JL, Postlethwaite AE. Interleukin-1 beta propeptide is detected intracellularly and extracellularly when, human monocytes are stimulated with LPS in vitro. J Exp Med 1994, 180, 607-614.
51. 51. Higgins GC, Foster JL, Postlethwaite AE. Synthesis and biological activity of human interleukin-1β propiece in vitro. Arthrit Rheumat 1993, 39, S153.
52. 52. Thornberry NA, Bull HG, Calaycay JR. et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356, 768-774.
53. 53. Rubartelli A, Bajetto A, Allavena G, et al. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 1992, 267, 24161-24164.
54. 54. Mignatti P, Rifkin DB. Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? J Cell Biochem 1991, 47, 201-217.
55. 55. Singer Il, Scott S, Chin J, et al. Interleukin-1β converting enzyme is localized on the external cell-surface membranes and in the cytoplasmic ground substance of activated human monocytes by immuno-electronmicroscopy (abs). Lymphokine Cytokine Res 1993, 12, 340.
56. 56. Li P, Allen H, Banerjee S, et al. Mice deficient in interleukin-1 converting enzyme (ICE) are defective in production of mature interleukin-1β and resistant to endotoxic shock. Cell 1995, 80, 401-411.
57. 57. Kuida K, Lippke JA, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 1995, 267, 2000-2003.
58. 58. Fantuzzi G, Zheng H, Faggioni R, et al. Effect of endotoxin in IL-1β-deficient mice. J Immunol 1996, 157, 291-296.
59. 59. Nakamura K, Okamura H, Wada M, et al. Endotoxin-induced serum factor that stimulates gamma inteferon production. Infect Immun 1989, 57, 590-595.
60. 60. Nakamura K, Okamura H, Nagata K, et al. Purification of a factor which provides a costimulatory signal for gamma Interferon production. Infect Immun 1993, 61, 64-70.
61. 61. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces interferon-γ. Nature 1995, 378, 88-91.
62. 62. Okamura H, Nagata K, Komatsu T, et al. A novel costimulatory factor for gamma Interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 1995, 63, 3966-3972.
63. 63. Heremans H, van Damme J, Dillen C, et al. Interferon-γ a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock in mice. J Exp Med 1990, 171, 1853-1861.
64. 64. Car BD, Eng VM, Schniyder B, et al. Interferon γ receptor deficient mice are resistant to endotoxic shock. J Exp Med 1994, 179, 1437-1444.
65. 65. Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Excherichia coli, and studies on the biologic activities of the protein. J Immunol 1996, 156, 4274-4279.
66. 66. Kohno K, Kataoka J, Ohtsuki T, et al. IFN-γ-inducing factor (IGIF) is a co-stimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997, 158, 1541-1550.
67. 67. Tsutsui H, Nakanishi K, Matsui K. et al. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996, 157, 3967-3973.
68. 68. Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997, 386, 619-623.
69. 69. Gu Y, Kuida K, Tsutsui H, et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 1997, 275, 206-209.
70. 70. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993, 54, 167-227.
71. 71. Haskill S, Martin M, VanLe L, et al. cDNA cloning of a novel form of the interleukin-1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991, 88, 3681-3685.
72. 72. Murzin AG, Lesk AM, Chothia C. β-trefoil fold Patterns of structure and sequence in the Kunitz inhibitors interleukins-1β and 1α and fibroblast growth factors, J Mol Biol 1992, 223, 531-543.
73. 73. Schreuder H, Tardif C, Trump-Kallmeyer S, et al. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 1997, 386, 194-200.
74. 74. Gruetter MG, van Oostrum J, Priestle JP, et al. A mutational analysis of receptor binding sites of interleukin-1β: differences in binding of human interleukin-1β muteins to human and mouse receptors. Protein Eng 1994, 7, 663-671.
75. 75. Lambriola-Tomkins E, Chandran C, Varnell TA, et al. Structure function analysis of human IL-1α: identification of residues required for binding to the human type I IL-1 receptor. Protein Eng 1993, 6, 535-539.
76. 76. Vigers GP, Gaffes P, Evans RJ, et al. X-ray structure of interleukin-1 receptor antagonist at 20-A resolution. J Biol Chem 1994, 269, 12874-12879.
77. 77. Evans RJ, Bray J, Childs JD, et al. Mapping receptor binding sites in the IL-1 receptor antagonist and IL-1β by site-directed mutagenesis: identification of a single site in IL-1Ra and two sites in IL-1β. J Biol Chem 1994, 270, 11477-11483.
78. 78. Dripps DJ, Brandhuber BJ, Thompson RC, et al. Effect of IL-1Ra on IL-1 signal transduction. J Biol Chem 1991, 266, 10331-10336.
79. 79. Bird TA, Saklatvala J. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism. J Immunol 1989, 142, 126-133.
80. 80. Crown J, Jakubowski A, Kemeny N, et al. A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluoruracil in patients with gastrointestinal cancer. Blood 1991, 78, 1420-1427.
81. 81. Crown J, Jakubowski A, Gabrilove J. Interleukin-1: biological effects in human hematopoiesis. Leuk Lymphoma 1993, 9, 433-440.
82. 82. Smith JW, Urba WJ, Curti BD, et al. The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J Clin Oncol 1992, 10, 1141-1152.
83. 83. Granowitz EV, Porat R, Mier JW, et al. Pharmacokinetics, saftey, and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992, 4, 353-360.
84. 84. Tewari A, Buhles WC Jr, Starnes HF Jr. Preliminary report: effects of interleukin-1 on platelet counts. Lancet 1990, 336, 712-714.
85. 85. Sims JE, Giri JG, Dower SK. The two interleukin-1 receptors play different roles in IL-1 activities. Clin Immunol Immunopathol 1994, 72, 9-14.
86. 86. Sims JE, Painter SL, Gow IR. Genomic organisation of the type I and type II IL-1 receptors. Cytokine 1995, 7, 483-490.
87. 87. Mantilla J, Ikejima I, Dinarello CA. Glycosylatton of the interleukin-1 receptor type I is required for optimal binding of interleukin-1. Lymphokine Cytokine Res 1992, 11, 197-205.
88. 88. Rosoff PM, Savage N, Dinarello CA. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 1988, 54, 73-81.
89. 89. Burch RM, Mahan LC. Oligonucleotides antisense to the interleukin-1 receptor mRNA block the effects of interleukin-1 in cultured murine and human fibroblasls and in mice. J Clin Invest 1991, 88, 1190-1196.
90. 90. Freshney NW, Rawlinson L. Guesdon F, et al. Interleukin-1 activates a novel protein cascade that results in the phosphorylalion of hsp27. Cell 1994, 78, 1039-1049.
91. 91. Gay NJ, Keith FJ. Drosophila Toll and IL-1 receptor. Nature 1991, 351, 355-356.
92. 92. Heguy A, Baldari CT, Macchia G, et al. Amino acids conserved in interleukin-1 receptors and the Drosophila Toll protein are essential for IL-1R signal transduction. J Biol Chem 1992, 267, 2605-2609.
93. 93. Vigers GPA, Anderson LJ, Caffes P, et al. Crystal structure of the type I interleukin-1 receptor complexed with interleukin-1β. Nature 1997, 386, 190-194.
94. 94. Wesche H, Korherr C, Kracht M, et al. The interleukin-1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 1997, 272, 7727-7731.
95. 95. Yoon D-Y, Dinarello CA. Regulation of IL-1 receptor type I and accessory protein by IL-10 (abs). Eur Cytokine Network 1996, 7, 547.
96. 96. Heguy A, Baldari CT, Censini S, et al. A chimeric type II/I interleukin-1 receptor can mediate interleukin-1 induction of gene expression in T cells. J Biol Chem 1993, 268, 10490-10494.
97. 97. Giri J, Newton RC, Horuk R. Identification of soluble interleukin-1 binding protein in cell-free supernatants. J Biol Chem 1990, 265, 17416-17419.
98. 98. Symons JA, Eastgate JA, Duff GW. Purification and characterization of a novel soluble receptor for interleukin-1. J Exp Med 1991, 174, 1251-1254.
99. 99. Symons JA, Young PA, Duff GW. The soluble interleukin-1 receptor: ligand binding properties and mechanisms of release. Lymphokine Cytokine Res 1993, 12, 381.
100. 100. Arend WP, Malyak M, Smith MF, et al. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 1994, 153, 4766-4774.
101. 101. Giri JG, Wells J, Dower SK, et al. Elevated levels of shed type II IL-1 receptor in sepsis. J Immunol 1994, 153, 5802-5813.
102. 102. Rossi B. IL-1 transduction signals. Eur Cytokine Network 1993, 4, 181-187.
103. 103. Mizel, S B. IL-1 signal transduction Eur Cytokine Netw. 1994, 5.
104. 104. Kuno K, Matsushima K. The IL-1 receptor signaling pathway. J Leuk Biol 1994, 56, 542-547.
105. 105. O'Neill LAJ. Towards and understanding of the signal transduction pathways for interleukin-1. Biochim Biophys Acta 1995, 1266, 31-44.
106. 106. Rosolf PM. Characterization of the interleukin-1-stimulated phospholipase C activity in human T lymphocytes. Lymphokine Res 1989, 8, 407-413.
107. 107. Rosoff PM. IL-1 receptors: structure and signals Seminars in Immunology, 1990, 2, 129-137.
108. 108. Schutze S, Machleidt T, Kronke M. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leuk Biol 1994, 56, 533-541.
109. 109. Andrieu N, Salvayre R, Levade T. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor necrosis factor and interleukin-1-induced sphimgomyelin cycle and cell proliferation in human fibroblasts. Biochem J 1994, 303, 341-345.
110. 2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. J Immunol 1992, 148, 155-160.
111. 111. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signalling. Cell 1994, 77, 325-328.
112. 2 by phosphorylation in rat mesangial cells. J Clin Invest 1994, 93, 1224-1233.
113. 113. Gallis B, Prickett KS, Jackson J, et al. IL-1 induces rapid phosphorylation of the IL-1 receptor. J Immunol 1989, 143, 3235-3240.
114. 114. Ye K, Koch K-C, Clark BD, et al. Interleukin-1 down regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA, whereas interleukin-2 increases its expression. Immunology 1992, 75, 427-434.
115. 115. Mizel SB. Cyclic AMP and interleukin-1 signal transduction. Immunol Today 1990, 11, 390-391.
116. 116. Munoz E, Beutner U, Zubiaga A, et al. IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 1990, 144, 964-969.
117. 117. Kester M, Siomonson MS, Mene P, et al. Interleukin-1 generates transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells. J Clin Invest 1989, 83, 718-723.
118. 118. Mathias S, Younes A, Kan C-C, et al. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 1993, 259, 519-522.
119. 119. Huwiler A, Pfeilschifter J. Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cells. FEBS Lett 1994, 350, 135-138.
120. 120. Kracht M, Truong O, Totty NF, et al. Interleukin-1α activates two forms of p54α mitogen-activated proetin kinase in rabbit liver. J Exp Med 1994, 180, 2017-2027.
121. 121. Kuno K, Okamoto S, Hirose K, et al. Structure and function of the intracellular portion of the mouse interleukin-1 receptor (Type I). J Biol Chem 1993, 268, 13510-13518.
122. 122. Croston GE, Cao Z, Goeddel DV. NFκB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 1995, 270, 16514-16517.
123. 123. Martin M, Bol GF, Eriksson A, et al. Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T-cells. Eur J Immunol 1994, 24, 1566-1571.
124. 124. Hopp TP. Evidence from sequence information that the interleukin-1 receptor is a transmembrane GTPase. Protein Sci 1995, 4, 1851-1859.
125. 125. Mitchum JL, Sims JE. IIP1: a novel human that interacts with the IL-1 receptor (abs). Cytokine 1995, 7, 595.
126. 126. Matsushima K, Kobayashi Y, Copeland TD, et al. Phosphorylation of a cytosolic 65-kDa protein induced by interleukin-1 in glucocorticoid pretreated normal human peripheral blood inononuclear leukocytes. J Immunol 1987, 139, 3367-3374.
127. 127. Bird TA. Sleath PR. de Roos PC, et al. Interleukin-1 represents a new modality for the activation of extracellular signal-related kinases/microtubule-associated protein-2 kinases. J Biol Chem 1991, 266, 22661-22670.
128. 128. Galcheva-Gargova Z, Dérijard B, Wu I-H, et al. An osmosensing signal transduction pathway in mammalian cells. Science 1994, 265, 806-809.
129. 129. Han J, Lee J-D, Bibbs L. et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265, 808-811.
130. 130. Shapiro L, Dinarello CA. Cytokine expression during osmotic stress. Exp Cell Res 1997, 231, 354-362.
131. 131. Zhang S, Han J, Sells MA, et al. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pakl. J Biol Chem 1995, 270, 23934-23936.
132. 132. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372, 739-747.
133. 133. Han J, Richter B, Lim Z, et al. Molecular cloning of human p38 MAP kinase. Biochim Biophys Acta 1995, 1265, 224-227.
134. 134. Cuenda A, Rouse J, Doza YN, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by stresses and interleukin-1. FEBS Lett 1995, 364, 229-233.
135. 135. DiDonato JA, Mercurio F, Karin M. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NFκB. Mol Cell Biol 1995, 15, 1302-1311.
136. 136. Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-derived protein kinase and protein kinase C. Mol Cell Biol 1989, 9, 2424-2430.
137. 137. Stylianou E, O'Neill LAJ, Rawlinson L, et al. Interleukin-1 induces NFκB through its type I but not type II receptor in lymphocytes. J Biol Chem 1992, 267, 15836-15841.
138. 138. Guesdon F, Waller RJ, Saklatvala J. Specific activation of β-casein kinase by the inflammatory cytokines interleukin-1 and tumour necrosis factor. Biochem J 1994, 304, 761-768.
139. 139. Bird TA, Downey H, Virca GD. Interleukin-1 regulates casein kinase II-mediated phosphorylation of the p65 subunit of NGκB (abs). Cytokine 1995, 7, 603.
140. 140. Muegge K, Williams TM, Kant J, et al. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 1989, 246, 249-251.
141. 141. Muegge K, Vila M, Gusella GL, et al. IL-1 induction of the c-jun promoter. Proc Natl Acad Sci USA 1993, 90, 7054-7058.
142. 142. O'Neill LAJ, Bird TA, Saklatvala J. Interleukin-1 signal transduction. Immunol Today 1990, 11, 392-394.